Clinical Trials Browser

Recruiting × Recurrence × Other solid neoplasm × Clear all

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Mesothelioma, Neoplasm Metastasis, Recurrence

NCT06725173 2026-03-18

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Recruiting

100 enrolled

Other solid neoplasm

Recurrence, Retinoblastoma

NCT06051695 2026-02-20

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Phase EARLY_PHASE1 Recruiting

10 enrolled

Other solid neoplasm

Recurrence, Retinoblastoma

Clinical Trials

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

EVEREST-2

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed